FDA Adverse Event Injury Summary report: N

HEMOBLAST BELLOWS

MDR report key: 8781502 · Received July 11, 2019

Report

Report Number
3007702492-2019-00001
Event Type
Injury
Date Received
July 11, 2019
Date of Event
February 27, 2019
Report Date
May 15, 2019
Manufacturer
BIOM'UP SA
Product Code
PMX
UDI-DI
03760193182705
PMA / PMN Number
P170012
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
UT, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE FILING OF THIS REPORT WAS DELAYED BECAUSE BIOM'UP MADE SEVERAL ATTEMPTS TO OBTAIN PATIENT INFORMATION AND DEVICE INFORMATION, SUCH AS LOT # AND EXPIRATION DATE, TO FACILITATE INVESTIGATION IF THE ISSUE, HOWEVER THE INFORMATION WAS NOT PROVIDED.

Description of Event or Problem · 1

PHYSICIAN PERFORMED CAPSULECTOMY AND REMOVED SUBPECTOL BREAST IMPLANT. HEMOBLAST BELLOWS WAS APPLIED OVER MUSCLE, ESPECIALLY IN AXILLARY REGION. THE AREA WAS OBSERVED TO BE DRY WHEN SKIN WAS CLOSED. WITHIN 7 HOURS POST-OP THE PATIENT HAD SWELLING ON LEFT SIDE. PATIENT WAS RETURNED TO OPERATING ROOM AND 500 - 1000 ML BLOOD WAS EVACUATED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
573307 HEMOBLAST BELLOWS HEMOSTATIC AGENT PMX BIOM'UP SA BQF02 03760193182705

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention